These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8666700)

  • 1. A longitudinal study of drug and alcohol use by psychosis-prone and impulsive-nonconforming individuals.
    Kwapil TR
    J Abnorm Psychol; 1996 Feb; 105(1):114-23. PubMed ID: 8666700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magical ideation and social anhedonia as predictors of psychosis proneness: a partial replication.
    Kwapil TR; Miller MB; Zinser MC; Chapman J; Chapman LJ
    J Abnorm Psychol; 1997 Aug; 106(3):491-5. PubMed ID: 9241953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Validation of the French translation of the impulsive nonconformity scale].
    Foullu S; Danet F; Dumas P; Brunelin J; Travart M; Elchardus JM; Saoud M; d'Amato T
    Encephale; 2008 Dec; 34(6):563-9. PubMed ID: 19081452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impulsive nonconformity as a trait contributing to the prediction of psychotic-like and schizotypal symptoms.
    Chapman LJ; Chapman JP; Numbers JS; Edell WS; Carpenter BN; Beckfield D
    J Nerv Ment Dis; 1984 Nov; 172(11):681-91. PubMed ID: 6491653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Putatively psychosis-prone subjects 10 years later.
    Chapman LJ; Chapman JP; Kwapil TR; Eckblad M; Zinser MC
    J Abnorm Psychol; 1994 May; 103(2):171-83. PubMed ID: 8040487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deviant olfactory experiences as indicators of risk for psychosis.
    Kwapil TR; Chapman JP; Chapman LJ; Miller MB
    Schizophr Bull; 1996; 22(2):371-82. PubMed ID: 8782292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Rasch analysis of three of the Wisconsin Scales of Psychosis Proneness: measurement of schizotypy.
    Graves RE; Weinstein S
    J Appl Meas; 2004; 5(2):160-71. PubMed ID: 15064535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The convergent and discriminant validity of the Chapman Scales.
    Bailey B; West KY; Widiger TA; Freiman K
    J Pers Assess; 1993 Aug; 61(1):121-35. PubMed ID: 8377097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using brief self-reports and clinician scales to screen for substance use disorders in psychotic patients.
    Møller T; Linaker OM
    Nord J Psychiatry; 2010 Apr; 64(2):130-5. PubMed ID: 19883188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bipolar spectrum-substance use co-occurrence: Behavioral approach system (BAS) sensitivity and impulsiveness as shared personality vulnerabilities.
    Alloy LB; Bender RE; Wagner CA; Whitehouse WG; Abramson LY; Hogan ME; Sylvia LG; Harmon-Jones E
    J Pers Soc Psychol; 2009 Sep; 97(3):549-65. PubMed ID: 19686007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is substance abuse in schizophrenia related to impulsivity, sensation seeking, or anhedonia?
    Dervaux A; Baylé FJ; Laqueille X; Bourdel MC; Le Borgne MH; Olié JP; Krebs MO
    Am J Psychiatry; 2001 Mar; 158(3):492-4. PubMed ID: 11229997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms and lifetime treatment experiences in psychotic patients with and without substance abuse.
    Møller T; Linaker OM
    Nord J Psychiatry; 2004; 58(3):237-42. PubMed ID: 15204212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Abuse of psychoactive drugs and social adjustment of psychotic patients].
    Lépine A; Côté G
    Can J Psychiatry; 1998 Dec; 43(10):1036-9. PubMed ID: 9868570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A ten-year longitudinal study of intense ambivalence as a predictor of risk for psychopathology.
    Kwapil TR; Raulin ML; Midthun JC
    J Nerv Ment Dis; 2000 Jul; 188(7):402-8. PubMed ID: 10919697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in schizotypic features in a large sample of young adults.
    Miller LS; Burns SA
    J Nerv Ment Dis; 1995 Oct; 183(10):657-61. PubMed ID: 7561812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of psychosis remission in psychotic disorders that co-occur with substance use.
    Caton CL; Hasin DS; Shrout PE; Drake RE; Dominguez B; Samet S; Schanzer B
    Schizophr Bull; 2006 Oct; 32(4):618-25. PubMed ID: 16873441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of psychosis proneness in African-American college students.
    Kwapil TR; Crump RA; Pickup DR
    J Clin Psychol; 2002 Dec; 58(12):1601-14. PubMed ID: 12455025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The abnormality of normal comparison groups: the identification of psychosis proneness and substance abuse in putatively normal research subjects.
    Butler RW; Jenkins MA; Braff DL
    Am J Psychiatry; 1993 Sep; 150(9):1386-91. PubMed ID: 8352351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.